Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
The Lancet, 10/13/09
Gilron I et al. – Combined gabapentin and nortriptyline seems to be more efficacious than either drug given alone for neuropathic pain, therefore the authors recommend use of this combination in patients who show a partial response to either drug given alone and seek additional pain relief. Future trials should compare other combinations to their respective monotherapies for treatment of such pain.
Related Articles
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
The Lancet - Early Online Publication, 10/01/09
Relevance Score: 85%
Popular Antidepressant Associated With A Dramatic Increase In Suicidal Thoughts Amongst Men, Study Finds
ScienceDaily, 10/16/09
Relevance Score: 80%
Drug Combo May Offer Best Relief for Nerve Pain
MedLinePlus, 10/01/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial
European Journal of Neurology, 11/21/09
Metabolic Alterations During Valproic Acid Treatment: A Prospective Study
Pediatric Neurology , 11/21/09
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Neurology, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


